Search - tctmd.com

Displaying 41 - 60 of 169

Sort: Relevancy | Date

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Daily News

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

L.A. McKeown

July 12, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2023

Shelley Wood

July 03, 2023

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

L.A. McKeown

June 06, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Conference News STS 2023

Earlier, More-Active Surgeon Involvement Needed in PE Care: AHA

Yael L. Maxwell

January 27, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Daily News

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Michael O'Riordan

September 27, 2022

Advertisement

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

What’s Going to Be Hot at ESC 2023?

TCTMD’s Top 10 Most Popular Stories for July 2023

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

TCTMD’s Top 10 Most Popular Stories for June 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

BP Reduction With Renal Denervation Still Evident a Decade On

Earlier, More-Active Surgeon Involvement Needed in PE Care: AHA

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

TCTMD’s Top 10 Most Popular Stories for December 2022

Top Endovascular News of 2022

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content